Cargando…
High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer
Most breast cancer (BC) patients succumb to metastatic disease. MiR-34a is a well-known tumor suppressive microRNA which exerts its anti-cancer functions by playing a role in p53, apoptosis induction, and epithelial-mesenchymal transition (EMT) suppression. Molecular Taxonomy of Breast Cancer Intern...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246662/ https://www.ncbi.nlm.nih.gov/pubmed/32357442 http://dx.doi.org/10.3390/ijms21093045 |
_version_ | 1783537998907834368 |
---|---|
author | Tokumaru, Yoshihisa Katsuta, Eriko Oshi, Masanori Sporn, Judith C. Yan, Li Le, Lan Matsuhashi, Nobuhisa Futamura, Manabu Akao, Yukihiro Yoshida, Kazuhiro Takabe, Kazuaki |
author_facet | Tokumaru, Yoshihisa Katsuta, Eriko Oshi, Masanori Sporn, Judith C. Yan, Li Le, Lan Matsuhashi, Nobuhisa Futamura, Manabu Akao, Yukihiro Yoshida, Kazuhiro Takabe, Kazuaki |
author_sort | Tokumaru, Yoshihisa |
collection | PubMed |
description | Most breast cancer (BC) patients succumb to metastatic disease. MiR-34a is a well-known tumor suppressive microRNA which exerts its anti-cancer functions by playing a role in p53, apoptosis induction, and epithelial-mesenchymal transition (EMT) suppression. Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) and The Cancer Genome Atlas (TCGA) cohorts were used to test our hypothesis that miR-34a high BCs translate to less aggressive cancer biology and better survival in large cohorts. There was no association between miR-34a expression levels and clinicopathological features of BC patients except for HER2 positivity. MiR-34a high expressing tumors were associated with lower Nottingham pathological grades and lower MKI67 expression. In agreement, high miR-34a tumors demonstrated lower GSVA scores of cell cycle and cell proliferation-related gene sets. High miR-34a tumors enriched the p53 pathway and apoptosis gene sets. Unexpectedly, high miR-34a tumors also associated with elevated EMT pathway score and ZEB1 and two expressions. MiR-34a expression did not associate with any distant metastasis. Further, high miR-34a tumors did not associate with better survival compared with miR-34a low tumors. In conclusion, the clinical relevance of miR-34a high expressing tumors was associated with suppressed cell proliferation, enhanced p53 pathway and apoptosis, but enhanced EMT and these findings did not reflect better survival outcomes in large BC patient cohorts. |
format | Online Article Text |
id | pubmed-7246662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72466622020-06-10 High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer Tokumaru, Yoshihisa Katsuta, Eriko Oshi, Masanori Sporn, Judith C. Yan, Li Le, Lan Matsuhashi, Nobuhisa Futamura, Manabu Akao, Yukihiro Yoshida, Kazuhiro Takabe, Kazuaki Int J Mol Sci Article Most breast cancer (BC) patients succumb to metastatic disease. MiR-34a is a well-known tumor suppressive microRNA which exerts its anti-cancer functions by playing a role in p53, apoptosis induction, and epithelial-mesenchymal transition (EMT) suppression. Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) and The Cancer Genome Atlas (TCGA) cohorts were used to test our hypothesis that miR-34a high BCs translate to less aggressive cancer biology and better survival in large cohorts. There was no association between miR-34a expression levels and clinicopathological features of BC patients except for HER2 positivity. MiR-34a high expressing tumors were associated with lower Nottingham pathological grades and lower MKI67 expression. In agreement, high miR-34a tumors demonstrated lower GSVA scores of cell cycle and cell proliferation-related gene sets. High miR-34a tumors enriched the p53 pathway and apoptosis gene sets. Unexpectedly, high miR-34a tumors also associated with elevated EMT pathway score and ZEB1 and two expressions. MiR-34a expression did not associate with any distant metastasis. Further, high miR-34a tumors did not associate with better survival compared with miR-34a low tumors. In conclusion, the clinical relevance of miR-34a high expressing tumors was associated with suppressed cell proliferation, enhanced p53 pathway and apoptosis, but enhanced EMT and these findings did not reflect better survival outcomes in large BC patient cohorts. MDPI 2020-04-26 /pmc/articles/PMC7246662/ /pubmed/32357442 http://dx.doi.org/10.3390/ijms21093045 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tokumaru, Yoshihisa Katsuta, Eriko Oshi, Masanori Sporn, Judith C. Yan, Li Le, Lan Matsuhashi, Nobuhisa Futamura, Manabu Akao, Yukihiro Yoshida, Kazuhiro Takabe, Kazuaki High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer |
title | High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer |
title_full | High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer |
title_fullStr | High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer |
title_full_unstemmed | High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer |
title_short | High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer |
title_sort | high expression of mir-34a associated with less aggressive cancer biology but not with survival in breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246662/ https://www.ncbi.nlm.nih.gov/pubmed/32357442 http://dx.doi.org/10.3390/ijms21093045 |
work_keys_str_mv | AT tokumaruyoshihisa highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT katsutaeriko highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT oshimasanori highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT spornjudithc highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT yanli highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT lelan highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT matsuhashinobuhisa highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT futamuramanabu highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT akaoyukihiro highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT yoshidakazuhiro highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer AT takabekazuaki highexpressionofmir34aassociatedwithlessaggressivecancerbiologybutnotwithsurvivalinbreastcancer |